Lineage Cell Therapeutics, Inc.
LCTX
$1.69
-$0.03-1.74%
AMEX
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -11.73% | 0.21% | 46.14% | -15.03% | -11.75% |
Total Receivables | 20.19% | -66.61% | 57.53% | 72.34% | 205.19% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -30.62% | -27.64% | 98.75% | -22.54% | -17.79% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 0.00% | -- | -- | -- | -- |
Total Current Assets | -12.28% | -1.99% | 48.24% | -14.83% | -11.65% |
|
|||||
Total Current Assets | -12.28% | -1.99% | 48.24% | -14.83% | -11.65% |
Net Property, Plant & Equipment | 0.47% | -7.78% | 0.46% | -4.93% | -7.20% |
Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Intangibles | -31.89% | 0.00% | 0.00% | 0.00% | 0.00% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1.39% | -17.92% | 1.32% | 1.34% | 0.34% |
Total Assets | -18.75% | -1.29% | 17.21% | -6.04% | -5.24% |
|
|||||
Total Accounts Payable | -24.96% | 69.93% | -26.58% | -33.04% | 8.01% |
Total Accrued Expenses | -0.97% | -30.03% | 48.12% | 9.43% | -24.25% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -11.19% | 2.43% | 1.32% | 1.97% | 1.27% |
Total Finance Division Other Current Liabilities | -24.15% | -6.19% | -10.45% | -9.76% | -9.54% |
Total Other Current Liabilities | -24.15% | -6.19% | -10.45% | -9.76% | -9.54% |
Total Current Liabilities | -17.82% | -6.35% | 0.82% | -9.24% | -9.56% |
|
|||||
Total Current Liabilities | -17.82% | -6.35% | 0.82% | -9.24% | -9.56% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 3.95% | -21.88% | -15.56% | -12.15% | -14.72% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 59.56% | -4.42% | 27.84% | -13.25% | 1.98% |
Total Liabilities | 28.12% | -5.82% | 13.86% | -11.49% | -4.18% |
|
|||||
Common Stock & APIC | 0.25% | 0.95% | 3.29% | 0.29% | 0.29% |
Retained Earnings | -7.47% | -1.03% | -0.82% | -0.76% | -1.47% |
Treasury Stock & Other | -52.85% | 6.78% | 0.48% | -17.00% | 10.86% |
Total Common Equity | -38.77% | 0.83% | 18.43% | -3.10% | -5.67% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -38.77% | 0.83% | 18.43% | -3.10% | -5.67% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 7.28% | -0.29% | 1.65% | 2.32% | -0.92% |
Total Equity | -39.33% | 0.83% | 18.86% | -3.11% | -5.80% |
|